Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis

Ads

You May Also Like

Aquinox to Present at Jefferies 2017 Global Healthcare Conference

VANCOUVER, British Columbia, June 01, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...